|
|
|
|
No restrictions for people with HIV/AIDS.
|
|
Doctors letter & HIV test for stays of more than 1 year.
|
|
Doctors prescription for entering with prescription medication mandatory.
|
HIV-specific entry and residence regulations for Chile
There are no restrictions for people with HIV/AIDS. There are no specific legal regulations concerning people with AIDS.
Neither a medical certificate nor an HIV test result is required when entering the country. Foreigners with a known HIV infection are not subject to specific residence regulations. There are no regulations regarding the control, deportation or expulsion of those concerned.
Antiretroviral medication can be carried for personal use (quantities according to duration of stay). It is recommended to carry a prescription.
(Source: 1)
The U.S. Department of State is unaware of any HIV/AIDS entry restrictions for visitors to or foreign residents of Chile.
(Source: 2)
Chile now requires a letter from a doctor including an HIV test for people who are applying for longer stay visas of 1 year or more.
Authors note: The consequences of this provision are not clear at the moment.
(Source:3)
HIV treatment information for Chile
no information available
HIV information / HIV NGOs in Chile
AHF Chile
Sta. Mónica 2317, Santiago, 8350574, Región Metropolitana, Chile.
T +56 9 4296 5801
[email protected]
Global Criminalisation of HIV Transmission Scan
The Global Criminalisation Scan is an initiative of GNP+. It aims to collect and keep up to date information on national and state level laws criminalising the transmission of or exposure to HIV. It also aims to provide an easily accessible ‘clearing-house’ of resources, research, and initiatives on the subject and to provide a platform for advocacy initiatives.
Find out more about the scan and the criminalisation of HIV transmission legislation at
http://criminalisation.gnpplus.net/.
Sources
- Embassy of Germany, Santiago de Chile, April 3, 2008
- US State Department Of State; Bureau of Consular Affairs; https://travel.state.gov / August 23, 2019; consulted June 22, 2021
July 17, 2023; consulted December 5, 2023
- User information, via e-mail, December 5, 2023
updated: 12/5/2023
Corrections and additions welcome. Please use the contact us form.